Pharmaceutical Technology26 天
FDA issues CRL to Astellas’ IZERVAY sNDA for geographic atrophy
Credit: fizkes/Shutterstock. The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the supplemental new drug application (sNDA) of Astellas Pharma’s IZERVAY ...
modernretina27 天
US FDA issues Complete Response Letter for avacincaptad pegol intravitreal solution (IZERVAY)
Astellas Pharma Inc. announced the United States Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for avacincaptad pegol intravitreal solution (IZERVAY). In the November ...